SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
Author:
Publisher
Frontiers Media SA
Subject
Endocrinology, Diabetes and Metabolism
Reference68 articles.
1. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice;Moynihan;Cell Metab.,2005
2. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1;Rodgers;Nature,2005
3. SIRT1: regulation of longevity via autophagy;Salminen;Cell Signal,2009
4. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network;Scarpulla;Biochim Biophys Acta,2011
5. Negative control of p53 by Sir2alpha promotes cell survival under stress;Luo;Cell,2001
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of glomerular sirtuin-1 and claudin-1 in the pathophysiology of nondiabetic focal segmental glomerulosclerosis;Scientific Reports;2023-12-19
2. Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review;Current Molecular Pharmacology;2023-12
3. Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy;Molecular and Cellular Endocrinology;2023-12
4. New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1;Biomedicine & Pharmacotherapy;2023-10
5. The role of N6-methyladenosine (m6A) in kidney diseases;Frontiers in Medicine;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3